When industry alliances collapse, the tremors often extend far beyond the boardroom. The Veeva-Salesforce split, finalized in 2025, is one…
Read More
When industry alliances collapse, the tremors often extend far beyond the boardroom. The Veeva-Salesforce split, finalized in 2025, is one…
Read MoreTelehealth was never meant to be a disruptor. But it became one. When the COVID-19 pandemic forced the healthcare system…
Read MorePharmaceutical marketing in 2025 is no longer confined to promotional brochures and sales reps. It sits at the confluence of…
Read MorePersonalized medicine isn’t the future. It’s already here. The global market is projected to reach $922 billion by 2030, driven…
Read MoreThe Food and Drug Administration’s (FDA) updated 2025 guidelines for pharmaceutical advertising on social media are forcing marketers to rethink…
Read MoreThe pharma marketing model is being torn down and rebuilt from the inside. This is not about replacing humans with…
Read MoreBiotech startups are often hailed for their innovative approaches to healthcare, but the lessons they offer extend far beyond just…
Read MoreIn 2025, pharmaceutical marketing is facing a transformative shift. Not because of a new regulatory crackdown, a blockbuster drug, or…
Read MoreIn the pharmaceutical industry, transparency in marketing is no longer optional—it is essential. Recent surveys reveal a significant trust gap…
Read MoreStep into a world where billions of dollars don’t chase cures but craft narratives, sway doctors, and capture your attention.…
Read More